Masters, S., Dunne, A., Subramanian, S., Hull, R., Tannahill, G., Sharp, F., . . . O'Neill, L. (2010). Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1ß 2 in type 2 diabetes. Nature Publishing Group.
Chicago Style (17th ed.) CitationMasters, S., et al. Activation of the NLRP3 Inflammasome by Islet Amyloid Polypeptide Provides a Mechanism for Enhanced IL-1ß 2 in Type 2 Diabetes. Nature Publishing Group, 2010.
MLA (9th ed.) CitationMasters, S., et al. Activation of the NLRP3 Inflammasome by Islet Amyloid Polypeptide Provides a Mechanism for Enhanced IL-1ß 2 in Type 2 Diabetes. Nature Publishing Group, 2010.
Warning: These citations may not always be 100% accurate.